Extended Survival in Patients With Non-Small-Cell Lung Cancer-Associated Brain Metastases in the Modern Era.

Assaf Berger,Reed Mullen,Kenneth Bernstein,Juan Diego Alzate,Joshua S Silverman,Erik P Sulman,Bernadine R Donahue,Abraham Chachoua,Elaine Shum,Vamsidhar Velcheti,Joshua Sabari,John G Golfinos,Douglas Kondziolka

Neurosurgery（2023）

引用 2|浏览10

暂无评分

摘要

Long-term survival in patients with brain metastases from NSCLC is feasible in the current era of SRS when combined with the use of effective targeted therapeutics. Of those living ≥5 years, the chance for living with stable disease without the need for active treatment for ≥3 years was 16%.

查看译文

关键词

cancer–associated brain metastases,lung cancer–associated,extended survival,small-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要